SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-23-042184
Filing Date
2023-11-21
Accepted
2023-11-20 20:37:49
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1266792
2 ex31-1.htm EX-31.1 17782
3 ex31-2.htm EX-31.2 17819
4 ex32-1.htm EX-32.1 8306
5 ex32-2.htm EX-32.2 8303
  Complete submission text file 0001493152-23-042184.txt   6580580

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cdt-20230930.xsd EX-101.SCH 62285
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cdt-20230930_cal.xml EX-101.CAL 70523
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cdt-20230930_def.xml EX-101.DEF 257462
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cdt-20230930_lab.xml EX-101.LAB 424841
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cdt-20230930_pre.xml EX-101.PRE 348493
68 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 929045
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41245 | Film No.: 231424231
SIC: 2834 Pharmaceutical Preparations